- Fee assured
- Awaiting verification
- Soft tissue
- Upper GI
Dr Bulusu has been appointed as the Consultant Oncologist at the Primrose Oncology Unit, Bedford hospital in 2002. He completed his postgraduate medical training from Osmania University in Hyderabad, India. He obtained his fellowship in clinical oncology from the Royal College of Radiologists after successfully completing his oncology training at the Beatson Oncology Centre, Glasgow, Addenbrookes Hospital, Cambridge and Churchill Hospital, Oxford. He has successfully completed the European certification examination in Medical Oncology.
His site specialist interests include Lymphomas, Lung cancer, Upper GI and pancreatic/biliary cancers and melanomas. He is the oncology lead in Bedford for Cancer Unknown Primary (CUP) and has been appointed as the lead for the Acute Oncology Team in November 2010. Dr Bulusu chairs the Primrose Oncology Systemic Therapy & Audit Group and co chairs the Upper GI Specialist MDT in the network.
Dr Bulusu has a keen interest in undergraduate and postgraduate teaching. He has been nominated as the Oncology Teacher of the Year for 5 years in succession from 2004-2008 by the medical students from the University of Cambridge. He is the educational supervisor for the Faculty of Clinical Oncology at the Royal College of Radiologists UK and a member of the Anglia deanery oncology regional educational training committee.
Dr Bulusu is the network lead and one of the national experts on Gastrointestinal Stromal Tumours (GIST), a rare sarcoma of the gastrointestinal tract. Working with the other specialists in this area, he has developed the national guidelines for the management of this tumour. He has lectured, presented and published extensively on this subject. He has been actively involved in numerous clinical trials at the cancer centre both as a principal and co investigator.
In 2013, Dr Bulusu has been appointed as the member of the Sarcoma group of National Cancer Research Institute. American Society of Clinical Oncology has appointed Dr Bulusu as a member of the Scientific Program Committee in Sarcoma for three year tenure. He is also an active member of the European Society of Medical Oncology, European Association of Cancer Research.
Areas of interest
• Lymphomas • Gastrointestinal stromal tumours; lung cancer; upper GI cancer;
Current NHS consultant posts held
Primrose Oncology Unit
Gastrointestinal stromal tumours
Listening to 1960s music
Oncology Teacher of the Year for 5 years in succession from 2004-2008 by the medical students from the University of Cambridge.
Distinguished Lecturer award from Hong Kong Tumour board 2012
Associate Lecturer Clinical School Cambridge University
Global excellence award from Liferaft Group USA in November 2014 recognising Dr Bulusu's achievements in wild type GISTS
(Additional) Languages spoken
British Journal of Cancer
Journal of Clinical Oncology (Conference Proceedings)
Annals of Oncology (Conference Proceedings)
Courses offered to GPs
Management of Lymphomas
Cancer Unknown Primary-Management Guidelines
Oncological emergencies for GPs
- Fellow of the Royal College of Radiologists (Faculty of Clinical Oncology) Royal College of Radiologists 1999
- MRCP Royal College of Physicians of Ireland 1988
- MSc (Oncology) Glasgow University 1990
- MD (General medicine) Osmania University 1986
Reference number 3600829
Professional bodies (positions held - last 3 yrs)
- Educational Supervisor Royal College of Radiologists (Faculty of Clinical Oncology) 2013
- Scientific Committee Member American Society of Clinical Oncology 2013
- Member Sarcoma Clinical Studies Group National Cancer Research Institute 2013
Details of entry to specialist register
- Clinical Oncology , 2002
Affiliations / memberships
American Society of Clinical Oncology
European Society of Medical Oncology
European Association of Cancer Research
British Medical Association
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.